New protein test could spot hidden uterine disease

NCT ID NCT06864494

Recruiting now Diagnosis Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is looking at whether a protein called L-PGDS can be used to diagnose adenomyosis, a condition where uterine tissue grows into the muscle wall, causing pain and heavy bleeding. Researchers will measure L-PGDS levels in vaginal swabs, blood, and urine from 60 women with and without adenomyosis. If L-PGDS levels differ between groups, it might lead to a simple, non-invasive diagnostic test.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple, non-invasive diagnostic test for adenomyosis using blood or urine, potentially catching the disease earlier.
What could go wrong: This is a small, early-stage study (60 participants) that only measures a protein level. It may not prove useful for diagnosis, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOMYOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenomyosis endometriosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADENOMYOSIS ENDOMETRIOSIS

Contacts and locations

Locations

CHU de Nimes
RECRUITING

Nîmes, 30029, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.